1996
DOI: 10.1007/bf00124462
|View full text |Cite
|
Sign up to set email alerts
|

Calculation of solvation and binding free energy differences between VX-478 and its analogs by free energy perturbation and AMSOL methods

Abstract: VX-478 belongs to a novel class of HIV-1 protease inhibitors that are based on N,N-disubstituted benzene sulfonamides. Force field parameters for the N,N-dialkyl benzene sulfonamide moiety have been assembled from the literature and from our own ab initio calculations. These parameters were employed to calculate solvation and binding free energy differences between VX-478 and two analogs. The free energy perturbation method has been used to determine these differences using two approaches. In the first approac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
21
0

Year Published

1998
1998
2012
2012

Publication Types

Select...
5
3
2

Relationship

0
10

Authors

Journals

citations
Cited by 31 publications
(23 citation statements)
references
References 24 publications
2
21
0
Order By: Relevance
“…Freeenergy perturbation and thermodynamic integration methods have been shown to determine free energy change within 1 kcal/ mol of the experimental values; hence they afford high accuracy (43). The thermodynamic integration approach takes into consideration several factors that are important for the accurate calculations of the pK a of ionizable groups.…”
Section: Resultsmentioning
confidence: 99%
“…Freeenergy perturbation and thermodynamic integration methods have been shown to determine free energy change within 1 kcal/ mol of the experimental values; hence they afford high accuracy (43). The thermodynamic integration approach takes into consideration several factors that are important for the accurate calculations of the pK a of ionizable groups.…”
Section: Resultsmentioning
confidence: 99%
“…Several of the clinical protease inhibitors were designed with the aid of molecular mechanics calculations, such as indinavir [35], and amprenavir [36]. The structural flexibility and opening of the protease flaps during the binding of an inhibitor have been studied by molecular dynamics [37][38][39][40].…”
Section: Molecular Mechanics Models and Simula-tionsmentioning
confidence: 99%
“…A structure-assisted drug design effort by Murcko and coworkers including FEP calculations contributed towards the discovery of the FDA-approved PR inhibitor amprenavir (formerly VX-478) [8385]. Additional successful applications of the FEP method for the calculation of HIV-1 PR inhibition, including non-peptide inhibitors, have been reported by McCarrick and Kollman [86], Rao and Murcko [87], Varney et al .…”
Section: Development Of Hiv-1 Inhibitors Guided By Fep Calculationsmentioning
confidence: 99%